PMV Pharmaceuticals (PMVP) Competitors $1.57 -0.02 (-1.26%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PMVP vs. STTK, ACRS, CMPS, ACIU, JSPR, DSGN, LYEL, SAGE, KOD, and PRQRShould you be buying PMV Pharmaceuticals stock or one of its competitors? The main competitors of PMV Pharmaceuticals include Shattuck Labs (STTK), Aclaris Therapeutics (ACRS), COMPASS Pathways (CMPS), AC Immune (ACIU), Jasper Therapeutics (JSPR), Design Therapeutics (DSGN), Lyell Immunopharma (LYEL), Sage Therapeutics (SAGE), Kodiak Sciences (KOD), and ProQR Therapeutics (PRQR). These companies are all part of the "pharmaceutical products" industry. PMV Pharmaceuticals vs. Shattuck Labs Aclaris Therapeutics COMPASS Pathways AC Immune Jasper Therapeutics Design Therapeutics Lyell Immunopharma Sage Therapeutics Kodiak Sciences ProQR Therapeutics Shattuck Labs (NASDAQ:STTK) and PMV Pharmaceuticals (NASDAQ:PMVP) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, valuation, profitability, dividends, risk, media sentiment and institutional ownership. Do insiders and institutionals have more ownership in STTK or PMVP? 58.7% of Shattuck Labs shares are held by institutional investors. Comparatively, 90.2% of PMV Pharmaceuticals shares are held by institutional investors. 10.5% of Shattuck Labs shares are held by company insiders. Comparatively, 7.6% of PMV Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has stronger earnings & valuation, STTK or PMVP? PMV Pharmaceuticals has lower revenue, but higher earnings than Shattuck Labs. PMV Pharmaceuticals is trading at a lower price-to-earnings ratio than Shattuck Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioShattuck Labs$6.44M8.23-$87.30M-$1.53-0.73PMV PharmaceuticalsN/AN/A-$68.96M-$1.00-1.57 Which has more volatility and risk, STTK or PMVP? Shattuck Labs has a beta of 1.85, indicating that its share price is 85% more volatile than the S&P 500. Comparatively, PMV Pharmaceuticals has a beta of 1.49, indicating that its share price is 49% more volatile than the S&P 500. Does the MarketBeat Community believe in STTK or PMVP? Shattuck Labs received 14 more outperform votes than PMV Pharmaceuticals when rated by MarketBeat users. Likewise, 71.15% of users gave Shattuck Labs an outperform vote while only 62.16% of users gave PMV Pharmaceuticals an outperform vote. CompanyUnderperformOutperformShattuck LabsOutperform Votes3771.15% Underperform Votes1528.85% PMV PharmaceuticalsOutperform Votes2362.16% Underperform Votes1437.84% Do analysts recommend STTK or PMVP? Shattuck Labs currently has a consensus price target of $8.67, indicating a potential upside of 680.78%. PMV Pharmaceuticals has a consensus price target of $5.80, indicating a potential upside of 269.43%. Given Shattuck Labs' higher possible upside, equities analysts clearly believe Shattuck Labs is more favorable than PMV Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shattuck Labs 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.40PMV Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17 Is STTK or PMVP more profitable? PMV Pharmaceuticals has a net margin of 0.00% compared to Shattuck Labs' net margin of -1,156.46%. PMV Pharmaceuticals' return on equity of -24.20% beat Shattuck Labs' return on equity.Company Net Margins Return on Equity Return on Assets Shattuck Labs-1,156.46% -61.92% -54.49% PMV Pharmaceuticals N/A -24.20%-21.67% Does the media prefer STTK or PMVP? In the previous week, Shattuck Labs had 13 more articles in the media than PMV Pharmaceuticals. MarketBeat recorded 13 mentions for Shattuck Labs and 0 mentions for PMV Pharmaceuticals. PMV Pharmaceuticals' average media sentiment score of 0.00 beat Shattuck Labs' score of -0.03 indicating that PMV Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Shattuck Labs Neutral PMV Pharmaceuticals Neutral SummaryPMV Pharmaceuticals beats Shattuck Labs on 9 of the 17 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get PMV Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PMVP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PMVP vs. The Competition Export to ExcelMetricPMV PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$81.24M$6.44B$5.06B$8.82BDividend YieldN/A8.11%5.17%4.07%P/E Ratio-1.5710.79125.9917.81Price / SalesN/A243.721,180.3874.38Price / CashN/A22.1633.8232.53Price / Book0.365.474.684.68Net Income-$68.96M$153.61M$119.54M$226.08M7 Day Performance-4.85%-4.32%-2.45%-2.04%1 Month Performance-0.63%-8.61%-4.06%0.06%1 Year Performance-36.95%28.79%29.86%24.60% PMV Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PMVPPMV Pharmaceuticals2.8132 of 5 stars$1.57-1.3%$5.80+269.4%-36.9%$82.28MN/A-1.5750STTKShattuck Labs2.8247 of 5 stars$1.11-2.6%$8.67+680.8%-50.7%$54.42M$1.66M0.00100Analyst RevisionACRSAclaris Therapeutics3.948 of 5 stars$3.96-13.7%$8.80+122.2%+321.2%$327.87M$31.25M0.0086Analyst UpgradeInsider TradeAnalyst RevisionNews CoverageGap DownCMPSCOMPASS Pathways2.8433 of 5 stars$4.66-2.1%$30.67+558.1%-23.0%$325.68MN/A0.00120Short Interest ↓ACIUAC Immune2.2991 of 5 stars$3.24-0.9%$12.00+270.4%+0.0%$323.54M$16.48M0.00140Positive NewsJSPRJasper Therapeutics2.6633 of 5 stars$20.98+1.4%$74.86+256.8%+227.3%$310.38MN/A0.0020DSGNDesign Therapeutics1.7541 of 5 stars$5.48flat$7.00+27.7%+145.7%$310.28MN/A0.0040LYELLyell Immunopharma0.4947 of 5 stars$1.03-7.2%$1.00-2.9%-46.9%$309.93M$130,000.00-1.30270High Trading VolumeSAGESage Therapeutics4.2697 of 5 stars$4.91flat$12.89+162.5%-75.1%$300.36M$86.46M-0.88690Analyst ForecastNews CoverageGap DownKODKodiak Sciences2.983 of 5 stars$5.79+2.7%$3.50-39.6%+138.3%$296.80MN/A0.0090PRQRProQR Therapeutics2.0614 of 5 stars$3.67+1.9%$7.13+94.1%+143.0%$294.05M$7.05M-11.47180 Related Companies and Tools Related Companies Shattuck Labs Alternatives Aclaris Therapeutics Alternatives COMPASS Pathways Alternatives AC Immune Alternatives Jasper Therapeutics Alternatives Design Therapeutics Alternatives Lyell Immunopharma Alternatives Sage Therapeutics Alternatives Kodiak Sciences Alternatives ProQR Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PMVP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMV Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PMV Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PMVP Stock Alerts